Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol

Department of Psychiatry, Douglas Hospital Research Centre, McGill University, 6875 Boulevard LaSalle, Montreal, Québec, Canada H4H 1R3.
British Journal of Pharmacology (Impact Factor: 4.99). 04/2004; 141(6):997-1005. DOI: 10.1038/sj.bjp.0705688
Source: PubMed

ABSTRACT 1. Resveratrol, an active ingredient of red wine extracts, has been shown to exhibit neuroprotective effects in several experimental models. 2. The present study evaluated the neuroprotective effects of resveratrol against amyloid beta(Abeta)-induced toxicity in cultured rat hippocampal cells and examined the role of the protein kinase C (PKC) pathway in this effect. 3. Pre-, co- and post-treatment with resveratrol significantly attenuated Abeta-induced cell death in a concentration-dependent manner, with a concentration of 25 microm being maximally effective. 4. Pretreatment (1 h) of hippocampal cells with phorbol-12-myristate-13-acetate, a PKC activator, at increasing concentrations (1-100 ng x ml(-1)), resulted in a dose-dependent reduction in Abeta-induced toxicity, whereas the inactive 4alpha-phorbol had no effect. 5. Pretreatment (30 min) of hippocampal cells with GF 109203X (1 microm), a general PKC inhibitor, significantly attenuated the neuroprotective effect of resveratrol against Abeta-induced cell death. 6. Treatment of hippocampal cells with resveratrol (20 microm) also induced the phosphorylation of various isoforms of PKC leading to activation. 7. Taken together, the present results indicate that PKC is involved in the neuroprotective action of resveratrol against Abeta-induced toxicity.

Download full-text


Available from: Wen Hua Zheng, Jul 16, 2015
  • Source
    • "Moreover, resveratrol slightly decreased the phosphorylation of PKC-d, but did not affect the phosphorylation of PKCí µí»¼/í µí»½II, PKC-í µí¼‡ (Ser916), and PKC-í µí¼ƒ (Thr538), suggesting that PKC-í µí»¿ (Thr505) was involved in the neuroprotective effects of resveratrol. In short, the PKC pathway played a major role in the neuroprotective-neurorescuing properties of resveratrol against Aí µí»½-induced toxicity in hippocampal neurons [43]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is the most common cause of dementia, but there is no effective therapy till now. The pathogenic mechanisms of AD are considerably complex, including Aβ accumulation, tau protein phosphorylation, oxidative stress, and inflammation. Exactly, resveratrol, a polyphenol in red wine and many plants, is indicated to show the neuroprotective effect on mechanisms mostly above. Recent years, there are numerous researches about resveratrol acting on AD in many models, both in vitro and in vivo. However, the effects of resveratrol are limited by its pool bioavailability; therefore researchers have been trying a variety of methods to improve the efficiency. This review summarizes the recent studies in cell cultures and animal models, mainly discusses the molecular mechanisms of the neuroprotective effects of resveratrol, and thus investigates the therapeutic potential in AD.
    BioMed Research International 11/2014; 2014:350516. DOI:10.1155/2014/350516 · 2.71 Impact Factor
  • Source
    • "The activation of protein kinase C (PKC) may stimulate α-secretase and then non-amyloidogenic pathway in APP processing, resulting in a reduction in the production of Aβ [53]. Our group reported that dihydrochloride3-(1-[3-(dimethylamino) propyl]-1H-indol-3yl)-4- (1H-indol-3-yl)-1H-pyrrole-2,5-dione (GF 109203X), a PKC inhibitor, attenuated the neuroprotective effects of resveratrol against Aβinduced toxicity in hippocampal cell cultures [38]. Moreover, Western blot data suggested that resveratrol (20–30 μM) induced the phosphorylation of the PKC delta (δ) isoform, whose inhibition is required for initiation of the apoptotic pathway [54]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-to-moderate red wine consumption appeared to reduce age-related neurological disorders including macular degeneration, stroke, and cognitive deficits with or without dementia. Resveratrol has been considered as one of the key ingredients responsible for the preventive action of red wine since the stilbene displays a neuroprotective action in various models of toxicity. Besides its well documented free radical scavenging and anti-inflammatory properties, resveratrol has been shown to increase the clearance of beta-amyloid, a key feature of Alzheimer's disease, and to modulate intracellular effectors associated with oxidative stress (e.g. heme oxygenase), neuronal energy homeostasis (e.g. AMP kinase), program cell death (i.e. AIF) and longevity (i.e. sirtuins). This article summarizes the most recent findings on mechanisms of action involved in the protective effects of this multi target polyphenol, and discusses its possible roles in the prevention of various age-related neurological disorders. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 10/2014; DOI:10.1016/j.bbadis.2014.09.011 · 5.09 Impact Factor
  • Source
    • "Grapes have been widely studied because of its antioxidant properties (Park et al. 2003; Zern and Fernandez 2005; Dani et al. 2007; Robb et al. 2008; Abeywardena and Leifert 2008). It is well described in the literature the neuroprotective activity of this fruit, especially in neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, as well as in metabolic diseases (e.g., diabetes and hypertension) (Sinha et al. 2002; Han et al. 2004; Raval et al. 2006; Vingtdeux et al. 2008; Xia et al. 2010; Venturini et al. 2011). In addition, the pathogenesis of these diseases are also linked by the raised of reactive species, failure of oxidative defenses, and elevated consumption of HFD (Moses et al. 2006; Puglielli 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Serra Gaucha is described as the most important wine region of Brazil. Regarding cultivars widespread in the Serra Gaucha, about 90 % of the area is occupied by vines of Vitis labrusca that is the most important specie used in grape juice production. The objective of this study was to investigate the antioxidant and neuroprotective effect of chronic intake of purple grape juice (organic and conventional) from Bordo variety (V. labrusca) on oxidative stress in different brain regions of rats supplemented with high-fat diet (HFD) for 3 months. A total of 40 male rats were randomly divided into 4 groups. Group 1 received a standard diet and water, group 2 HFD and water, group 3 HFD and conventional grape juice (CGJ), and group 4 HFD and organic grape juice (OGJ). All groups had free access to food and drink and after 3 months of treatment the rats were euthanized by decapitation and the cerebral cortex, hippocampus and cerebellum isolated and homogenized on ice for oxidative stress analysis. We observed that the consumption of calories in HFD and control groups, were higher than the groups supplemented with HFD and grape juices and that HFD diet group gain more weight than the other animals. Our results also demonstrated that HDF enhanced lipid peroxidation (TBARS) and protein damage (carbonyl) in cerebral cortex and hippocampus, reduced the non-enzymatic antioxidants defenses (sulfhydryl) in cerebral cortex and cerebellum, reduced catalase and superoxide dismutase activities in all brain tissues and enhanced nitric oxide production in all cerebral tissues. CGJ and OGJ were able to ameliorate these oxidative alterations, being OGJ more effective in this protection. Therefore, grape juices could be useful in the treatment of some neurodegenerative diseases associated with oxidative damage.
    Cellular and Molecular Neurobiology 08/2013; DOI:10.1007/s10571-013-9978-8 · 2.20 Impact Factor
Show more